Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion.

Pubmed ID: 15243924

Journal: The Journal of infectious diseases

Publication Date: Aug. 1, 2004

Affiliation: Department of Laboratory Medicine, University of California, San Francisco 94118, USA. murphy@itsa.ucsf.edu

MeSH Terms: Humans, Male, Adult, Female, Aged, Risk Factors, Cohort Studies, Middle Aged, Sex Factors, Blood Donors, DNA, Viral, Cross-Sectional Studies, HTLV-I Infections, HTLV-II Infections, Blood Transfusion, Human T-lymphotropic virus 1, Human T-lymphotropic virus 2, Viral Load, Proviruses, Leukocytes, Mononuclear

Grants: N01-HB-47114, N01-HB-97078, N01-HB-97079, N01-HB-97080, N01-HB-97081, N01-HB-97082, R01-HL-62235, N01-HB-97077

Authors: Lee TH, Murphy EL, Nass CC, Wang B, Smith D, Chafets D, Loughlin K

Cite As: Murphy EL, Lee TH, Chafets D, Nass CC, Wang B, Loughlin K, Smith D, HTLV Outcomes Study Investigators. Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion. J Infect Dis 2004 Aug 1;190(3):504-10. Epub 2004 Jul 6.

Studies:

Abstract

BACKGROUND: High human T lymphotropic virus (HTLV)-I provirus load (VL) has been associated with an increased risk of HTLV-associated myelopathy, but little is known about variation in HTLV-I or -II VLs by demographic characteristics and risk behaviors. METHODS: We measured HTLV-I and HTLV-II VLs in a large cohort of 127 HTLV-I-seropositive and 328 HTLV-II-seropositive former blood donors, by use of real-time polymerase chain reaction using tax primers. Multivariable linear regression was used to control for confounding by relevant covariates. RESULTS: The mean VLs were 3.28 log(10) copies/10(6) peripheral blood mononuclear cells (PBMCs) (range, 0.5-5.3 log(10) copies/10(6) PBMCs) for HTLV-I and 2.60 log(10) copies/10(6) PBMCs (range, 0.05-5.95 log(10) copies/10(6) PBMCs) for HTLV-II (P<.0001). HTLV-II VLs were higher in those subjects with subtype A infection (mean, 2.82 log(10) copies/10(6) PBMCs) than in those with subtype B infection (mean, 2.29 log(10) copies/10(6) PBMCs) (P=.005). Higher HTLV-I VL was associated with previous receipt of a blood transfusion (P=.04), and lower HTLV-II VL was associated with female sex (P=.007). These associations persisted in virus-specific multivariate linear regression models controlling for potential confounding variables. CONCLUSIONS: VL was significantly higher in HTLV-I than in HTLV-II infection and was higher in HTLV-II subtype A than in HTLV-II subtype B infection. Chronic HTLV VLs may be related to the infectious dose acquired at the time of infection, with higher VLs following acquisition by blood transfusion and lower VLs following sexual acquisition.